These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 37523026)

  • 1. Correction to: "Fertility in Acromegaly: A Single-Center Experience of Female Patients During Active Disease and After Disease Remission".
    J Clin Endocrinol Metab; 2024 Sep; 109(10):e1990. PubMed ID: 38843034
    [No Abstract]   [Full Text] [Related]  

  • 2. The socioeconomic burden of acromegaly.
    Störmann S; Cuny T
    Eur J Endocrinol; 2023 Aug; 189(2):R1-R10. PubMed ID: 37536267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increase in intracellular and extracellular myocardial mass in patients with acromegaly: a cardiac magnetic resonance imaging study.
    Wolf P; Bouazizi K; Kachenoura N; Piedvache C; Gallo A; Salenave S; Maione L; Young J; Prigent M; Lecoq AL; Kuhn E; Agostini H; Trabado S; Redheuil A; Chanson P; Kamenický P
    Eur J Endocrinol; 2023 Aug; 189(2):199-207. PubMed ID: 37549351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex differences in mortality in patients with acromegaly: a nationwide cohort study in Korea.
    Kim J; Hong N; Choi J; Moon JH; Kim EH; Hong JW; Lee EJ; Kim SG; Ku CR
    Eur J Endocrinol; 2023 Aug; 189(2):225-234. PubMed ID: 37548222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined Afirma Genomic Sequencing Classifier and TERT promoter mutation detection in molecular assessment of Bethesda III-VI thyroid nodules.
    Ladenson PW; Klopper JP; Hao Y; Kaushik P; Walsh PS; Huang J; Kloos RT; Ali SZ
    Cancer Cytopathol; 2023 Oct; 131(10):609-613. PubMed ID: 37544986
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term, real-world experience of pasireotide dose reduction in patients with acromegaly.
    Marques NV; Wildemberg LEA; Gadelha MR
    Endocr Connect; 2023 Aug; 12(10):. PubMed ID: 37530039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of endoscopic transsphenoidal surgery for acromegaly: Comparison of using and not using the floor standing pneumatic powered endoscope-holder system.
    Tosaka M; Yamaguchi R; Horiguchi K; Ozawa A; Matsumoto S; Honda F; Hokama Y; Yoshida T; Okano M; Tsukada A; Ishiuchi S; Yamada M; Yoshimoto Y
    Heliyon; 2024 Aug; 10(15):e35647. PubMed ID: 39170435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acromegaly and COVID-19, lessons, and new opportunities.
    Varlamov EV; Fleseriu M
    Pituitary; 2024 May; ():. PubMed ID: 38819618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in acromegaly comorbidities, treatment, and outcome over three decades: a nationwide cohort study.
    Rosendal C; Arlien-Søborg MC; Nielsen EH; Andersen MS; Feltoft CL; Klose M; Andreassen M; Bruun NH; Jørgensen JOL; Dal J
    Front Endocrinol (Lausanne); 2024; 15():1380436. PubMed ID: 38638137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidentally detected acromegaly: single-center study of surgically treated patients over 22 years.
    Giraldi EA; Veledar E; Oyesiku NM; Ioachimescu AG
    J Investig Med; 2021 Feb; 69(2):351-357. PubMed ID: 33148631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of acromegaly by endoscopic transsphenoidal surgery: surgical experience in 214 cases and cure rates according to current consensus criteria.
    Hazer DB; Işık S; Berker D; Güler S; Gürlek A; Yücel T; Berker M
    J Neurosurg; 2013 Dec; 119(6):1467-77. PubMed ID: 24074496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving criteria for post-operative biochemical remission of acromegaly: can we achieve a definitive cure? An audit of surgical results on a large series and a review of the literature.
    Minniti G; Jaffrain-Rea ML; Esposito V; Santoro A; Tamburrano G; Cantore G
    Endocr Relat Cancer; 2003 Dec; 10(4):611-9. PubMed ID: 14713271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing presentation of acromegaly in half a century: a single-center experience.
    Demir AN; Sulu C; Kara Z; Sahin S; Ozaydin D; Sonmez O; Keskin FE; Tanriover N; Gazioglu N; Kadioglu P
    Pituitary; 2023 Oct; 26(5):573-582. PubMed ID: 37523026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
    Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
    Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A follow-up study on outcomes of endoscopic transsphenoidal approach for acromegaly.
    Aydin S; Ozoner B; Sahin S; Alizada O; Comunoglu N; Oz B; Gazioglu N; Kadioglu P; Tanriover N
    Clin Neurol Neurosurg; 2020 Nov; 198():106201. PubMed ID: 32927330
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.